Lyell Immunopharma

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LYEL and other ETFs, options, and stocks.

About LYEL

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. 

CEO
Elizabeth Homans
CEOElizabeth Homans
Employees
190
Employees190
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2018
Founded2018
Employees
190
Employees190

LYEL Key Statistics

Market cap
1.81B
Market cap1.81B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
984.18K
Average volume984.18K
High today
$7.69
High today$7.69
Low today
$7.24
Low today$7.24
Open price
$7.33
Open price$7.33
Volume
1.44M
Volume1.44M
52 Week high
$15.50
52 Week high$15.50
52 Week low
$3.57
52 Week low$3.57

LYEL Earnings

-$0.89
-$0.59
-$0.30
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 11, Pre-Market
ActualExpected Nov 11, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.